75651

Chesa Flores is a 55-year-old female who presents to the clinic with abdominal pain and frequent watery diarrhea that has been occurring for just under two days. She estimates at least ten loose stools per day, raising concern for fluid and electrolyte loss, even though she has been trying to stay hydrated with water, Gatorade, and soup. She denies recent travel, and her temperature is only mildly elevated at 99.5°F, with no reported blood in the stool or other findings suggesting dysentery. Her physical examination is generally reassuring aside from hyperactive bowel sounds, and her blood pressure of 105/65 mmHg and heart rate of 91 beats/min warrant continued attention to her hydration status. Her past medical history is limited to allergic rhinitis, and her only routine medication is loratadine (Claritin) 10 mg by mouth daily. Given her short symptom duration, watery stools, no travel, and lack of high fever or bloody diarrhea, her presentation most likely reflects uncomplicated acute community-acquired diarrhea, which is often viral and typically resolves with supportive care rather than antibiotics. Most individuals with acute diarrhea can maintain their fluid and electrolyte needs through oral intake, including water, sports drinks, soups, and other sources of salt and fluids (Aghsaeifard et al., 2022). 

The ACG Clinical Guideline for the diagnosis, treatment, and prevention of acute diarrheal infections in adults supports supportive management as the primary approach for Chesa. The guideline recommends maintaining hydration and replacing electrolytes and notes that routine empiric antibiotic treatment is not recommended for community-acquired acute diarrhea because most cases are viral and antibiotics generally do not shorten the illness (Riddle et al., 2016). Stool diagnostic studies may be considered when patients have dysentery, moderate-to-severe illness, symptoms lasting more than seven days, or circumstances associated with an outbreak or increased risk of transmitting disease. Although Chesa is having frequent stools, she has had symptoms for less than 48 hours and currently has no high fever or bloody diarrhea, so immediate empiric antimicrobial therapy would not be routinely indicated. For symptom relief, the guideline notes loperamide as an effective antimotility medication that slows intestinal movement and allows greater fluid absorption. It recommends an initial adult dose of 4 mg, followed by 2 mg after subsequent watery stools, and emphasizes short-term use and the lowest effective dose because constipation and complications can occur, particularly with inflammatory bacterial diarrhea. Therefore, the overall plan should focus on continued hydration, careful symptom monitoring, and short-term antidiarrheal treatment when no signs of invasive infection are present.

My professional assessment is that short-term loperamide is a reasonable pharmacological option for Chesa because her frequent watery stools are interfering with normal functioning, and she currently has no clinical findings that would make an antimotility medication inappropriate. I would prescribe loperamide 2 mg tablets, dispense 16 tablets, with instructions to take two tablets (4 mg) orally after the first loose stool, followed by one tablet (2 mg) after each subsequent loose stool, using the lowest effective dose and discontinuing treatment within 48 hours. No refills are appropriate because this is intended only for an acute, self-limited episode. Loperamide decreases intestinal motility and promotes additional fluid absorption, which can reduce stool frequency and provide symptom relief (Riddle et al., 2016). I would select generic substitution as permitted because Chesa has no clinical indication for the brand-name Imodium product. I would also reinforce that medication is secondary to adequate oral hydration. Importantly, she should stop loperamide and seek further evaluation if she develops bloody stools, significant fever, worsening or severe abdominal pain, abdominal distention, or persistent diarrhea because antimotility medications may prolong illness or contribute to complications when inflammatory bacterial colitis is present. Antibiotics would not be prescribed empirically at this time because the ACG specifically discourages their routine use for community-acquired diarrhea when there is no evidence suggesting an invasive bacterial infection (Dereje et al., 2023).

Before finalizing Chesa’s treatment plan, I would ask several additional questions to identify possible infectious causes and determine whether further testing is needed. I would ask whether she has had blood or mucus in the stool, nausea or vomiting, severe or localized abdominal pain, dizziness, decreased urine output, recent antibiotic use, hospitalization or healthcare exposure, sick contacts, consumption of undercooked meat or seafood, unpasteurized foods, restaurant meals, untreated water, or exposure to anyone with similar gastrointestinal symptoms. I would also ask about her ability to continue drinking fluids and urinating normally because more than ten watery stools per day can lead to dehydration and electrolyte abnormalities even when the patient is attempting oral replacement. If symptoms worsen or signs of dehydration develop, I would consider laboratory evaluation with a basic metabolic panel to assess sodium, potassium, bicarbonate, BUN, and creatinine and determine whether intravenous fluid replacement is necessary. Stool testing would become more appropriate if she develops bloody diarrhea, significant fever, severe abdominal pain, symptoms suggesting an outbreak, or diarrhea that persists beyond approximately seven days, which is consistent with ACG recommendations for more significant or prolonged illness. I would advise Chesa to continue fluids containing both electrolytes and carbohydrates, monitor urine output and symptoms closely, and follow up within 24–48 hours if she is not clearly improving. She should seek urgent evaluation sooner for inability to maintain oral hydration, syncope or significant dizziness, worsening abdominal pain, bloody stools, increasing fever, confusion, or markedly decreased urination.

References

Aghsaeifard, Z., Heidari, G., & Alizadeh, R. (2022). Understanding the use of oral rehydration therapy: A narrative review from clinical practice to main recommendations. Health Science Reports, 5(5), e827. https://doi.org/10.1002/hsr2.827

Dereje, B., Yibabie, S., Keno, Z., & Megersa, A. (2023). Antibiotic utilization pattern in treatment of acute diarrheal diseases: The case of Hiwot Fana Specialized University Hospital, Harar, Ethiopia. Journal of Pharmaceutical Policy and Practice, 16(1), 62. https://doi.org/10.1186/s40545-023-00568-7

Riddle, M. S., DuPont, H. L., & Connor, B. A. (2016). ACG clinical guideline: Diagnosis, treatment, and prevention of acute diarrheal infections in adults. The American Journal of Gastroenterology, 111(5), 602–622. https://doi.org/10.1038/ajg.2016.126

Needs help with similar assignment?

We are available 24x7 to deliver the best services and assignment ready within 3-4 hours? Order a custom-written, plagiarism-free paper

Get Answer Over WhatsApp Order Paper Now